J.L. Vizmanos

2.0k total citations
54 papers, 1.2k citations indexed

About

J.L. Vizmanos is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, J.L. Vizmanos has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 21 papers in Hematology and 13 papers in Genetics. Recurrent topics in J.L. Vizmanos's work include Acute Myeloid Leukemia Research (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Chronic Myeloid Leukemia Treatments (9 papers). J.L. Vizmanos is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Chronic Myeloid Leukemia Treatments (9 papers). J.L. Vizmanos collaborates with scholars based in Spain, United Kingdom and Italy. J.L. Vizmanos's co-authors include Francisco J. Novo, Marı́a José Calasanz, María José Larráyoz, Carlos J. González-Navarro, Paula Aranaz, M. García‐Delgado, Idoya Lahortiga, María D. Odero, Rita Yolanda Cavero and María Isabel Calvo and has published in prestigious journals such as Bioinformatics, PLoS ONE and Cancer Research.

In The Last Decade

J.L. Vizmanos

53 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.L. Vizmanos Spain 22 615 316 214 164 130 54 1.2k
Dawei Cai China 14 539 0.9× 156 0.5× 102 0.5× 212 1.3× 102 0.8× 28 998
Uma B. Dasgupta India 18 615 1.0× 147 0.5× 153 0.7× 33 0.2× 145 1.1× 39 1.2k
Koji Nagai Japan 30 915 1.5× 121 0.4× 96 0.4× 284 1.7× 107 0.8× 97 2.1k
Ali Shawki United States 16 365 0.6× 619 2.0× 257 1.2× 31 0.2× 60 0.5× 37 1.5k
David Gilot France 25 1.0k 1.7× 205 0.6× 173 0.8× 34 0.2× 347 2.7× 54 2.2k
Shigeki Saito Japan 24 940 1.5× 197 0.6× 173 0.8× 99 0.6× 252 1.9× 67 2.4k
H Riedel Germany 20 430 0.7× 502 1.6× 383 1.8× 51 0.3× 45 0.3× 44 1.4k
Olga Protchenko United States 21 1.2k 1.9× 281 0.9× 116 0.5× 30 0.2× 285 2.2× 29 1.9k
Richard Edwards United Kingdom 24 580 0.9× 147 0.5× 88 0.4× 34 0.2× 202 1.6× 55 1.5k
Daniel Vyoral Czechia 19 510 0.8× 466 1.5× 279 1.3× 30 0.2× 73 0.6× 33 1.2k

Countries citing papers authored by J.L. Vizmanos

Since Specialization
Citations

This map shows the geographic impact of J.L. Vizmanos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.L. Vizmanos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.L. Vizmanos more than expected).

Fields of papers citing papers by J.L. Vizmanos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.L. Vizmanos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.L. Vizmanos. The network helps show where J.L. Vizmanos may publish in the future.

Co-authorship network of co-authors of J.L. Vizmanos

This figure shows the co-authorship network connecting the top 25 collaborators of J.L. Vizmanos. A scholar is included among the top collaborators of J.L. Vizmanos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.L. Vizmanos. J.L. Vizmanos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martínez‐López, Ana L., Carlos J. González-Navarro, Maite Solas, et al.. (2024). Zein nanoparticles extend lifespan in C. elegans and SAMP8 mice. International Journal of Pharmaceutics. 666. 124798–124798. 1 indexed citations
2.
Espuelas, Socorro, et al.. (2023). Mucus-penetrating and permeation enhancer albumin-based nanoparticles for oral delivery of macromolecules: Application to bevacizumab. Drug Delivery and Translational Research. 14(5). 1189–1205. 7 indexed citations
3.
4.
Martínez‐Irujo, Juan J., et al.. (2023). Monitoring Caenorhabditis elegans molting in a conventional luminometer. MethodsX. 10. 102235–102235.
5.
Martínez‐López, Ana L., Carlos J. González-Navarro, Paula Aranaz, J.L. Vizmanos, & Juan M. Irache. (2021). In vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions. Acta Pharmaceutica Sinica B. 11(4). 989–1002. 20 indexed citations
6.
Vizmanos, J.L., et al.. (2020). Improvement of antioxidant activity of oregano (Origanum vulgare L.) with an oral pharmaceutical form. Biomedicine & Pharmacotherapy. 129. 110424–110424. 26 indexed citations
7.
Cavero, Rita Yolanda, et al.. (2019). A Simple and a Reliable Method to Quantify Antioxidant Activity In Vivo. Antioxidants. 8(5). 142–142. 78 indexed citations
8.
Martínez-Ohárriz, María Cristina, Zhongwei Gu, Yiyan He, et al.. (2018). Cyclodextrin-grafted poly(anhydride) nanoparticles for oral glibenclamide administration. In vivo evaluation using C. elegans. International Journal of Pharmaceutics. 547(1-2). 97–105. 21 indexed citations
9.
Sánchez‐Montes, Gregorio, Jinliang Wang, Arturo H. Ariño, J.L. Vizmanos, & Íñigo Martínez‐Solano. (2017). Reliable effective number of breeders/adult census size ratios in seasonal‐breeding species: Opportunity for integrative demographic inferences based on capture–mark–recapture data and multilocus genotypes. Ecology and Evolution. 7(23). 10301–10314. 18 indexed citations
10.
Aranaz, Paula, C. Ormazábal, Marı́a José Calasanz, et al.. (2010). A new potential oncogenic mutation in the FERM domain of JAK2 in BCR/ABL1-negative and V617F-negative chronic myeloproliferative neoplasms revealed by a comprehensive screening of 17 tyrosine kinase coding genes. Cancer Genetics and Cytogenetics. 199(1). 1–8. 7 indexed citations
11.
Vizmanos, J.L., et al.. (2009). Signatures of Selection in Fusion Transcripts Resulting From Chromosomal Translocations in Human Cancer. PLoS ONE. 4(3). e4805–e4805. 19 indexed citations
12.
Novo, Francisco J., et al.. (2007). TICdb: a collection of gene-mapped translocation breakpoints in cancer. BMC Genomics. 8(1). 33–33. 64 indexed citations
13.
Novo, Francisco J. & J.L. Vizmanos. (2006). Chromosome translocations in cancer: computational evidence for the random generation of double-strand breaks. Trends in Genetics. 22(4). 193–196. 13 indexed citations
14.
Lahortiga, Idoya, Elena Belloni, Iria Vázquez, et al.. (2005). NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2. Cancer Genetics and Cytogenetics. 157(2). 151–156. 4 indexed citations
15.
Vizmanos, J.L., Francisco J. Novo, E. Joanna Baxter, et al.. (2004). NIN , a Gene Encoding a CEP110-Like Centrosomal Protein, Is Fused to PDGFRB in a Patient with a t(5;14)(q33;q24) and an Imatinib-Responsive Myeloproliferative Disorder. Cancer Research. 64(8). 2673–2676. 48 indexed citations
16.
Agirre, Xabier, Francisco J. Novo, Marı́a José Calasanz, et al.. (2003). TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia. Molecular Carcinogenesis. 38(4). 201–208. 54 indexed citations
17.
Agirre, Xabier, J.L. Vizmanos, Marı́a José Calasanz, et al.. (2003). Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients. Oncogene. 22(7). 1070–1072. 65 indexed citations
18.
Vizmanos, J.L., R J Jaju, Giovanni Martinelli, et al.. (2002). Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL negative chronic myeloproliferative disorders.. Journal of Medical Genetics. 39. 1 indexed citations
19.
Vizmanos, J.L., Carlos J. González-Navarro, Francisco J. Novo, et al.. (1998). Degree and distribution of variability in the 5' untranslated, E1, E2/NS1 and NS5 regions of the hepatitis C virus (HCV). Journal of Viral Hepatitis. 5(4). 227–240. 15 indexed citations
20.
Vizmanos, J.L., et al.. (1995). The GCGGAA gene-regulatory motif of herpes simplex virus type-1 is also found in hepatitis C virus. Gene. 154(1). 131–132. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dawei Cai Breakdown of academic impact, for papers by Uma B. Dasgupta Breakdown of academic impact, for papers by Koji Nagai Breakdown of academic impact, for papers by Ali Shawki Breakdown of academic impact, for papers by David Gilot Breakdown of academic impact, for papers by Shigeki Saito Breakdown of academic impact, for papers by H Riedel Breakdown of academic impact, for papers by Olga Protchenko Breakdown of academic impact, for papers by Richard Edwards Breakdown of academic impact, for papers by Daniel Vyoral
Rankless by CCL
2026